We might also see the first batch of medicines appear in 2022, if we can successfully prevent ICU visits with effective medicines for starters, that would mean a lot to healthcare professionals worldwide.
Two studies in Brazil have shown a pretty significant reduction in hospitalizations in a RCT of fluvoxamine. More data obviously required.
Plus there has been more work on other treatments, but most are pretty expensive.
https://www.vox.com/future-perfect/22619137/fluvoxamine-covi...